Literature DB >> 18286476

Diagnosis and management of pleomorphic sarcomas (so-called "MFH") in adults.

Alessandra F Nascimento1, Chandrajit P Raut.   

Abstract

The existence of "malignant fibrous histiocytoma" ("MFH") as a distinct entity is controversial. Previously accepted as the most common sarcoma affecting adults, it is now known to comprise a heterogeneous group of tumors without a specific known line of differentiation. Reclassification of many tumors in this group afforded better prognostication, but traditional treatments still apply. Pleomorphic soft tissue tumors for which a line of differentiation is debatable are presently categorized as undifferentiated pleomorphic sarcoma. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18286476     DOI: 10.1002/jso.20972

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  36 in total

1.  Systematic therapy for unresectable or metastatic soft-tissue sarcomas: past, present, and future.

Authors:  Sherif S Morgan; Lee D Cranmer
Journal:  Curr Oncol Rep       Date:  2011-08       Impact factor: 5.075

2.  Soft tissue sarcoma with metastasis to the stomach: a case report.

Authors:  Lemuel Leon Dent; Cesar Yamil Cardona; Michael Clause Buchholz; Roosevelt Peebles; Julie Denise Scott; Derrick Jerome Beech; Billy Ray Ballard
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

3.  Metastatic cerebral malignant fibrous histiocytoma masquerading as neurocysticercosis.

Authors:  Jerome J Graber; Ambika Nayar; David Zagzag
Journal:  J Neurooncol       Date:  2011-05-05       Impact factor: 4.130

4.  Neoadjuvant HIFU treatment for malignant fibrous histiocytoma: report of a case.

Authors:  Meiqi Zhou; Xiaoye Hu; Haifei He; Jiani Chen; Lirong Chen; Yongchuan Deng
Journal:  J Med Ultrason (2001)       Date:  2012-06-02       Impact factor: 1.314

5.  Giant malignant fibrous histiocytoma of the testis.

Authors:  Volkan Ülker; Hasan Anıl Atalay; Çağlar Çakır; Aytül Sargan
Journal:  Turk J Urol       Date:  2017-12-19

6.  Increased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphoma.

Authors:  Agnieszka W Kubica; Peter S Rose; Amy L Weaver; Jerry D Brewer
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

7.  miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.

Authors:  Laura Pazzaglia; Chiara Novello; Amalia Conti; Serena Pollino; Piero Picci; Maria Serena Benassi
Journal:  Cell Oncol (Dordr)       Date:  2016-11-29       Impact factor: 6.730

8.  A practical and comprehensive immunohistochemical approach to the diagnosis of superficial soft tissue tumors.

Authors:  Wael Al-Daraji; Ehab Husain; Bettena G Zelger; Bernhard Zelger
Journal:  Int J Clin Exp Pathol       Date:  2008-06-10

9.  Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience.

Authors:  Ronald S A de Vreeze; Daphne de Jong; Petra M Nederlof; Aafke Ariaens; Ivon H G Tielen; Luc Frenken; Rick L Haas; Frits van Coevorden
Journal:  Ann Surg Oncol       Date:  2010-03       Impact factor: 5.344

10.  Analysis of multiple sarcoma expression datasets: implications for classification, oncogenic pathway activation and chemotherapy resistance.

Authors:  Panagiotis A Konstantinopoulos; Elena Fountzilas; Jeffrey D Goldsmith; Manoj Bhasin; Kamana Pillay; Nancy Francoeur; Towia A Libermann; Mark C Gebhardt; Dimitrios Spentzos
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.